SAEM Clinical Images Series: Perioral Facial Swelling

The patient is a 40-year-old male with no significant past medical history who presents to the Emergency Department with perioral rash and swelling. He had been in his normal state of health the day before and woke up in the morning with an itchy rash around his mouth. He denies lip, tongue, or intraoral swelling, throat itching or sensation of throat swelling, trouble swallowing, or swelling or itching of any other part of his face. The rash has not changed locations nor has it spread beyond the perioral area. He noted a similar episode once or twice before in his life, which had improved with taking diphenhydramine. He denies the presence of a rash or itching on any other part of his body, wheezing, shortness of breath, GI symptoms, or dizziness. He denies any exposure to new foods or medications, and he has not been exposed to ACE inhibitors nor ARBs. He has no other complaints at this time.

Vitals: BP 141/97; HR 88; R 19; T 98.2°F; O2 sat 98% on room air.

General: Awake and alert, no distress, speaking in a clear voice.

HEENT: As shown in the images provided. There is no oropharyngeal swelling. There is no stridor.

Respiratory: Clear to auscultation, no wheezes.

Skin: There is no rash or swelling elsewhere on the patient’s body.

Non-contributory

Upon further questioning, the patient admitted to applying an “instant hair dye shampoo” to his facial hair the day before presentation. Review of the product ingredients revealed para-phenylenediamine. He later recalled that his previous episodes of peri-oral swelling had occurred after exposure to the same product. Para-phenylenediamine can be found in commercial black and dark brown hair dyes, as well as in henna tattoos. Reactions can range from local erythema and contact dermatitis to bullous dermatitis and significant edema in severely affected patients. Symptoms may appear similar to angioedema and may only be distinguished after careful history identifies hair dye or henna exposure. Initial management is to remove the offending dye or henna with thorough washing. Topical steroids or a short course of oral steroids can be used for severe symptoms. Prevention of exposures in sensitized individuals remains the most important tenet of care. Hair dyes recommend consumers test the dye on a small patch of skin prior to using it, which has been proven to help identify those who will develop a reaction.

Take-Home Points

  • Para-phenylenediamine is a compound found in henna and hair dye that is commonly responsible for adverse skin reactions, but may be under recognized when used for facial hair.

  • Allergic contact dermatitis from this compound may show a range of clinical skin findings and sometimes may mimic angioedema.

  • Mukkanna KS, Stone NM, Ingram JR. Para-phenylenediamine allergy: current perspectives on diagnosis and management. J Asthma Allergy. 2017 Jan 18;10:9-15. doi: 10.2147/JAA.S90265. PMID: 28176912; PMCID: PMC5261844.
  • Krasteva M, Cristaudo A, Hall B, Orton D, Rudzki E, Santucci B, Toutain H, Wilkinson J. Contact sensitivity to hair dyes can be detected by the consumer open test. Eur J Dermatol. 2002 Jul-Aug;12(4):322-6. PMID: 12095875.



ALiEM AIR Series | Endocrine Module (2026)

ALiEM U

 

Welcome to the AIR ENDOCRINE Module! After carefully reviewing all relevant posts in the past 12 months from the top 50 sites of the Digital Impact Factor [1], the ALiEM AIR Team is proud to present the highest quality online content related to endocrine emergencies in the Emergency Department. 11 blog posts met our standard of online excellence and were approved for residency training by the AIR Series Board. More specifically, we identified 6 AIR and 5 Honorable Mentions. We recommend programs give 5.5 hours of III credit for this module.

 

AIR Stamp of Approval and Honorable Mentions

 

In an effort to truly emphasize the highest quality posts, we have 2 subsets of recommended resources. The AIR stamp of approval is awarded only to posts scoring above a strict scoring cut-off of ≥30 points (out of 35 total), based on our scoring instrument. The other subset is for “Honorable Mention” posts. These posts have been flagged by and agreed upon by AIR Board members as worthwhile, accurate, unbiased, and appropriately referenced despite an average score.

 

Take the Endocrine Module at ALiEMU

 

Interested in taking the AIR quiz for fun or asynchronous (Individualized Interactive Instruction) credit? Please go to the above link. You will need to create a free, 1-time login account.

 

Highlighted Quality Posts: Endocrine 2025

 

SiteArticleAuthorDateLabel
EMCritHyperosmolar hyperglycemic state (HHS)Dr. Josh FarkasJune 1, 2024

AIR

EMCritHypokalemiaDr. Josh FarkasJuly 4, 2024AIR
EMCritHyperkalemiaDr. Josh FarkasNovember 5, 2024AIR
EMCritHyperkalemiaDr. Josh FarkasJuly 4, 2024AIR
EMCritHyponatremiaDr. Josh FarkasJuly 4, 2024AIR
EM OttawaThese are the Roids you are looking for – Steroids in the EdDr. Naman AroraJanuary 9, 2025AIR
EMCrit

Hypernatremia and dehydration in the ICU

Dr. Josh FarkasJuly 5, 2024AIR
Rebel EMHyperkalemiaDr. Anand SwaminathanJune 26, 2024HR
EM DocsAlcohol WithdrawalDr. Kyler OsborneDecember 18, 2024HR
St Emlyns BlogGLP-1A tocxicity: What do emergency clinicians need to know about drugs like ozempic and wegovy?Dr. Gregory YatesNovember 24, 2024HR
UMEM PearlsEuglycemic DKA Pitfalls and PearlsDr. Cody CouperusAugust 20, 2024HR

 

(AIR = Approved Instructional Resource; HM = Honorable Mention)

 

If you have any questions or comments on the AIR series, or this AIR module, please contact us!

Reference

    1. Lin M, Phipps M, Chan TM, et al. Digital Impact Factor: A Quality Index for Educational Blogs and Podcasts in Emergency Medicine and Critical Care. Ann Emerg Med. 2023;82(1):55-65. doi:10.1016/j.annemergmed.2023.02.011, PMID 36967275

 

 

SAEM Clinical Images Series: Green Foot

The patient is a 59-year-old male with a history of prior DVT, atrial fibrillation, HTN, alcohol use and COPD who presents to the Emergency Department with chest pain, dyspnea, and left lower extremity swelling and pain. He had a prior hospital admission two weeks ago for leg swelling and cellulitis. He was previously prescribed oral gentamicin and topical mupirocin for concerns of foot infection, which he has been compliant with taking. He has been working long hours as a construction worker, but knows of no chemical exposure to his feet and denies walking barefoot. He has had no fever and denies any other complaints at this time.

Vitals: BP 151/69; HR 93; R 18; T 97.7°F; O2 sat 95% room air.

General: No acute distress.

Respiratory: Mild wheezes bilaterally.

Extremities: Mild bilateral lower extremity swelling, worse on left compared to right. Left foot discolored as shown in the image – when asked, the patient states the discoloration started initially on the great toenail and progressed to the sole of the foot.

CBC: WBC: 10.2; Hgb: 12.7

Na: 130

ESR: 6

CRP: 0.8

CXR: Mild pulmonary edema.

Foot X-ray: No acute findings, old Lisfranc injury.

Ultrasound: Negative for DVT.

Green foot syndrome is a rarely diagnosed Pseudomonas aeruginosa infection secondary to chronic skin moisture of the feet, identified from the greenish discoloration of skin. The green discoloration is due to pyocyanin and pyoverdine, giving the skin a bluish-green color. Symptoms can also include pruritus, pain, malodor, and paresthesias. Our patient was admitted to the hospital with dermatology consultation, who recommended vinegar soaks, gentamicin cream, and 0.3% ciprofloxacin solution. Other case studies have reported successful treatment by removing the inciting agent and keeping skin dry, acidic soaks such as benzoyl peroxide, and/or oral fluoroquinolones. Green foot syndrome has been reported in soldiers wearing combat boots for long hours and in patients during prolonged cast use. The moist environment of damp skin in boots provides an ideal environment for P. aeruginosa to grow. Our patient often wore construction boots with 2 pairs of socks for long hours at work, which made him susceptible to this infection.

Take-Home Points

  • When patients present with lower extremity complaints, always carefully assess the feet; this patient’s initial complaint was not skin discoloration.

  • Pseudomonas aeruginosa infections can cause a greenish discoloration to feet chronically kept in moist conditions, such as frequent and extended shoe or cast use.

  • García-Martínez FJ, López-Martín I, Castellanos-González M, Segurado-Rodríguez MA. Green foot ulcers. Enferm Infecc Microbiol Clin. 2017 Oct;35(8):536-537. English, Spanish. doi: 10.1016/j.eimc.2015.10.010. Epub 2015 Nov 26. PMID: 26627144.
  • Spernovasilis N, Psichogiou M, Poulakou G. Skin manifestations of Pseudomonas aeruginosa infections. Curr Opin Infect Dis. 2021 Apr 1;34(2):72-79. doi: 10.1097/QCO.0000000000000717. PMID: 33492004.
  • Wu DC, Chan WW, Metelitsa AI, Fiorillo L, Lin AN. Pseudomonas skin infection: clinical features, epidemiology, and management. Am J Clin Dermatol. 2011 Jun 1;12(3):157-69. doi: 10.2165/11539770-000000000-00000. PMID: 21469761.
  • Sloan B, Meffert JJ. “Boot foot” with pseudomonas colonization. J Am Acad Dermatol. 2005;52(6):1109-1110. doi:10.1016/j.jaad.2005.01.105
  • Park, Y., & Bae, J. (2013). Green foot syndrome: A case series of 14 patients from an armed forces hospital. Journal of the American Academy of Dermatology, 69(4), e198-e199. https://doi.org/10.1016/j.jaad.2013.05.012
  • Lee SH, Cho SB. Cast-related green foot syndrome. Clin Exp Dermatol. 2009;34(7):2008-2009. doi:10.1111/j.1365-2230.2009.03317.x
  • Macgregor DM. An unusual presentation of immersion foot. Br J Sports Med. 2004 Aug;38(4):E11. doi: 10.1136/bjsm.2003.007385. PMID: 15273204; PMCID: PMC1724852.



SAEM Clinical Images Series: Connect the Dots

The patient is a 39-year-old female with past medical history of polysubstance use disorder and seizures who presents to the Emergency Department complaining of bilateral leg pain, primarily in her joints. She states that she was seen by her PCP today and was given a shot of Toradol, but she reports that her pain has continued to worsen to the point that she has difficulty ambulating. She states that two days ago she developed pruritic blisters on her feet and her feet began to swell. She reports the blisters have worsened and have spread to her hands and forearms as well as her calves and thighs. She denies ever having similar symptoms in the past. She reports some subjective fevers and chills as well as cough and congestion, but denies sore throat, chest pain, abdominal pain, vomiting, diarrhea, dysuria, vaginal bleeding, or vaginal discharge. She denies any recent travel and denies any animal exposure other than her mother’s dog but there are no fleas that she knows of. She denies any recent insect bites. She states that she has been sexually active with one male partner over the last six months and that she has tested negative for STIs in the last two months. She has no other complaints at this time.

Vitals: BP 121/77; HR 107; R 22; T 100.8°F; O2 sat 98% room air.

General: Appears mildly uncomfortable but no acute distress.

HEENT: Normal, no signs of pharyngitis.

Respiratory: Clear to auscultation bilaterally.

Cardiovascular: Tachycardia without murmur.

Abdomen: Non-tender, no masses.

Extremities: There are no signs of trauma. Full range of motion but complaints of joint pain with moving her legs and with walking.

Skin: Relevant findings as shown. Discrete, tender, erythematous macules and vesicles on the bilateral feet, calves, forearms and a singular vesicle of the right1st digit

Urinalysis: Small amount of bacteria

This patient has disseminated gonococcal infection.

Disseminated gonococcal infection (DGI) is a serious complication of untreated gonorrhea, potentially leading to severe complications such as septic arthritis, pustular skin lesions, tenosynovitis, and in rare cases, endocarditis or meningitis. DGI is characterized by fevers, polyarticular joint pain, and skin lesions. The diagnosis of disseminated gonorrhea should be considered in any patient presenting with polyarticular joint pain or swelling in the setting of petechial or pustular skin lesions, especially in high risk populations. The skin lesions of disseminated gonorrhea most commonly appear on the distal extremities, and may involve the palms and soles. Patients may also present with acute septic arthritis without an obvious source. Patients with gonoccocal bacteremia may show signs of perihepatitis, meningitis, endocarditis, or osteomyelitis. Disseminated gonococcal infection results from the hematogenous spread of N gonorrhoeae, and typically develops within 3 weeks of primary mucosal infection. Patients with disseminated gonoccocal infection should be admitted for intravenous antibiotics (ceftriaxone). Any sexual partners should be treated as well.

Take-Home Points

  • Consider disseminated gonorrhea when you have a patient with polyarticular joint pain/swelling with pustular skin lesions.

  • Complications of DGI may be severe; admission and aggressive treatment with intravenous antibiotics is warranted.

  • Tang et al. Characterizing the rise of disseminated gonococcal infections in California, July 2020-July 2021. Clin Infect Dis. January 2023;76(2):194-200.
  • Wang CH, Lu CW. Images of the month 2: Disseminated gonococcal infection presenting as the arthritis-dermatitis syndrome. Clin Med (Lond). 2019 Jul;19(4):340-341. doi: 10.7861/clinmedicine.19-4-340. PMID: 31308120; PMCID: PMC6752240.



SAEM Clinical Images Series: Bilateral Leg Swelling with a Uterine Twist

The patient is a 40-year-old female who presents to the Emergency Department with bilateral leg swelling. Her symptoms started six days prior and have progressively worsened. Her symptoms are associated with shortness of breath with no chest pain. The patient has taken an over-the-counter diuretic, which has helped with her symptoms. She also reports intermittent vaginal bleeding for the past two months, with a LMP that was two months prior. She is not currently on contraceptives, and does endorse unprotected intercourse over this time. The patient denies headache, blurry vision, nausea or vomiting, abdominal pain, urinary complaints, diarrhea or constipation. She has no other complaints at this time.

Vitals: BP 140/86; HR 97; R 14; T 99°F; O2 sat 99% on room air.

General: Well appearing, no acute distress.

Respiratory: Clear to auscultation.

Cardiovascular: Regular rate and rhythm, no murmur.

Abdomen: Soft, nondistended, nontender.

Extremities: Trace bilateral pitting edema. Normal range of motion, neurovascularly intact, equal pulses bilaterally.

Neurological: No focal neurological deficits.

Hgb: 9.6 (previously 13.3 two years prior)

Creatinine: Normal

BNP: 706 pg/mL

Serum -HCG: 874,342 mIU/ml

This patient has a complete molar pregnancy.

Molar pregnancy is part of a spectrum of gestational trophoblastic tumors that include benign hydatidiform moles, locally invasive moles, and choriocarcinoma. Patients classically present with painless first or early second trimester vaginal bleeding with uterine size larger than expected gestational age and excessively high β-hcg levels. Some patients develop anemia, hyperemesis gravidarum, clinical hyperthyroidism, and signs of preeclampsia including hypertension, headaches, proteinuria and edema. Acute respiratory distress can occur due to embolization of trophoblastic tissue into the pulmonary vasculature, thyrotoxicosis, or simple fluid overload. Management involves removal of molar tissue through D&C or dilation and suction evacuation. Histopathologic examination of the products of conception is the gold standard for the diagnosis of a molar pregnancy. β-hcg levels are then monitored to ensure complete resolution and to detect any signs of persistent trophoblastic disease. In some cases, adjunct chemotherapy or even hysterectomy may be needed.

Take-Home Points

  • Molar pregnancy can be diagnosed with excessively high β-hcg levels and an ultrasound that shows a classic “snowstorm” or “bunches of grapes” finding.

  • Consider gestational trophoblastic disease in any patient with signs and symptoms of preeclampsia prior to 20 weeks gestation.

  • Cavaliere A, Ermito S, Dinatale A, Pedata R. Management of molar pregnancy. J Prenat Med. 2009 Jan;3(1):15-7. PMID: 22439034; PMCID: PMC3279094.
  • Soper, John T. MD. Gestational Trophoblastic Disease: Current Evaluation and Management. Obstetrics & Gynecology 137(2):p 355-370, February 2021. | DOI: 10.1097/AOG.0000000000004240



By |2026-01-31T19:31:26-08:00Feb 6, 2026|Ob/Gyn, SAEM Clinical Images|
Go to Top